Lv1
10 积分 2025-05-05 加入
Prognostic value of LI-RADS category on gadoxetic acid–enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas
6小时前
待确认
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT
6小时前
已完结
Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma
7小时前
已完结
Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma
9小时前
已完结
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
17天前
已完结
MRI imaging features for evaluating the efficacy and prognosis of TACE combined with targeted immunotherapy in unresectable hepatocellular carcinoma
1个月前
已完结
Precision Risk Stratification in Hepatocellular Carcinoma: Clinical Relevance of CatBoost-based Prediction Following TACE
1个月前
已完结
MRI-Based Quantification of Intratumoral Heterogeneity Predicts Response in Hepatocellular Carcinoma Treated with Atezolizumab-Bevacizumab and TACE/HAIC
1个月前
已完结
Prediction of therapeutic response to transarterial chemoembolization plus systemic therapy regimen in hepatocellular carcinoma using pretreatment contrast-enhanced MRI based habitat analysis and Crossformer model
1个月前
已完结
Gadoxetic Acid–enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma
1个月前
已完结
皖公网安备34019202002308
